Header Logo

Connection

ELIAS JOSEPH JABBOUR to Drug Synergism

Back to Details
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about Drug Synergism.
ELIAS JOSEPH JABBOUR
Connection Strength
0.031
Drug Synergism
  1. Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. Cancer. 2018 07 01; 124(13):2758-2765.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.